Kalaris Therapeutics, Inc.
KLRS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001754068
No open-market purchases or sales by Kalaris Therapeutics, Inc. insiders were filed in the last 90 days; 56 institutions reported holding it in 13F filings for Q2 2026, worth $73.4M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Kalaris Therapeutics, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 58 | 56 | −2 |
| Shares | 18.6M | 18.0M | −547.8K (−2.9%) |
| Value | $107.2M | $73.4M | −$33.8M (−31.5%) |
New holders (9)
Institutions that held Kalaris Therapeutics, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 95,772 | $389.8K | 0.00% |
| Verdad Advisers, LP | 80,297 | $326.8K | 0.31% |
| Pale Fire Capital SE | 39,626 | $161.3K | 0.01% |
| Trexquant Investment LP | 29,737 | $121.0K | 0.00% |
| Quadrature Capital Ltd | 16,527 | $67.3K | 0.00% |
| Dimensional Fund Advisors LP | 15,958 | $65.0K | 0.00% |
| Virtu Financial LLC | 10,845 | $44.0K | 0.00% |
| Sigma Planning Corp | 10,167 | $41.4K | 0.00% |
| Caitong International Asset Management Co., Ltd | 7 | $28 | 0.00% |
Sold out (11)
Institutions that held Kalaris Therapeutics, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Paradigm Biocapital Advisors LP | 700,000 | $4.04M |
| Propel Bio Management, LLC | 295,771 | $1.72M |
| Kalehua Capital Management LLC | 135,585 | $782.3K |
| Simplify Asset Management Inc. | 87,426 | $504.4K |
| Millennium Management LLC | 59,534 | $343.5K |
| 683 Capital Management, LLC | 45,000 | $259.6K |
| Qube Research & Technologies Ltd | 11,103 | $64.1K |
| Johnson Financial Group, Inc. | 10,000 | $57.7K |
| Citigroup Inc | 8,703 | $50.2K |
| Fortitude Family Office, LLC | 114 | $658 |
| Federated Hermes, Inc. | 34 | $196 |